New drug combo shows promise for tough liver cancer
Disease control
Ongoing
This study tests a combination of two drugs, pembrolizumab and bavituximab, in 35 adults with advanced liver cancer that cannot be treated with surgery or local therapies. The goal is to see if the combination shrinks tumors and improves survival. Participants must not have had p…
Phase: PHASE2 • Sponsor: David Hsieh • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC